{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:39:24Z","timestamp":1784947164212,"version":"3.55.0"},"reference-count":343,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-099001-B-I00"],"award-info":[{"award-number":["RTI2018-099001-B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RD16\/0011\/0012"],"award-info":[{"award-number":["RD16\/0011\/0012"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017SGR-1408"],"award-info":[{"award-number":["2017SGR-1408"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["Marie Sk\u0142odowska-Curie grant agreement No 722779"],"award-info":[{"award-number":["Marie Sk\u0142odowska-Curie grant agreement No 722779"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"DOI":"10.3389\/fncel.2020.00250","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T13:08:24Z","timestamp":1597151304000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?"],"prefix":"10.3389","volume":"14","author":[{"given":"Cristina","family":"Salado-Manzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unai","family":"Perpi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Straccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Molina-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Canals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"B1","author":"Abbas","year":"2017","journal-title":"Cellular and Molecular Immunology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/466S6a","article-title":"Levodopa: the story so far.","volume":"466","author":"Abbott","year":"2010","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.stemcr.2018.03.007","article-title":"hPSC-derived striatal cells generated using a scalable 3D hydrogel promote recovery in a huntington disease mouse model.","volume":"10","author":"Adil","year":"2018","journal-title":"Stem Cell Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.5772\/intechopen.81224","article-title":"Trends of protein aggregation in neurodegenerative diseases.","volume":"88","author":"Agbas","year":"2019","journal-title":"Neurochem. Basis Brain Funct. Dysfunct."},{"key":"B5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/WCO.0b013e32833b1f62","article-title":"Cell transplantation in Parkinson\u2019s disease: problems and perspectives.","volume":"23","author":"Allan","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of huntington\u2019s disease phenotypes in induced pluripotent stem cells.","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B7","first-page":"79","author":"Annett","year":"2013","journal-title":"Mesenchymal Stem Cells for Trinucleotide Repeat Disorders."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1242\/dev.117093","article-title":"Activin A directs striatal projection neuron differentiation of human pluripotent stem cells.","volume":"142","author":"Arber","year":"2015","journal-title":"Development"},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1227\/01.NEU.0000073315.88827.72","article-title":"Autotransplantation of human carotid body cell aggregates for treatment of Parkinson\u2019s disease.","volume":"53","author":"Arjona","year":"2003","journal-title":"Neurosurgery"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12324-0","article-title":"MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates.","volume":"10","author":"Aron Badin","year":"2019","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejphar.2015.03.038","article-title":"Translational research for Parkinson\u2019s disease: the value of pre-clinical primate models.","volume":"759","author":"Aron Badin","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","article-title":"A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules.","volume":"212","author":"Aspelund","year":"2015","journal-title":"J. Exp. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"16707","DOI":"10.1073\/pnas.0808488105","article-title":"Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats.","volume":"105","author":"Aubry","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response.","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/exnr.1999.7239","article-title":"Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington\u2019s disease.","volume":"161","author":"Bachoud-L\u00e9vi","year":"","journal-title":"Exp. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1089\/10430340050111377","article-title":"Neuroprotective gene therapy for Huntington\u2019s disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.","volume":"11","author":"Bachoud-L\u00e9vi","year":"","journal-title":"Hum. Gene Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington\u2019s disease after neural transplantation.","volume":"356","author":"Bachoud-L\u00e9vi","year":"","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington\u2019s disease 6 years after surgery: a long-term follow-up study.","volume":"5","author":"Bachoud-L\u00e9vi","year":"2006","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3171\/JNS.1985.62.2.0169","article-title":"Transplantation of adrenal medullary tissue to striatum in parkinsonism.","volume":"5","author":"Backlund","year":"1985","journal-title":"Fernstrom Found. Ser."},{"key":"B20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.vetimm.2012.09.022","article-title":"The evolutionary basis for differences between the immune systems of man, mouse, pig and ruminants.","volume":"152","author":"Bailey","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2741\/1217","article-title":"Implantation of Spheramine\u00ae in advanced Parkinson\u2019s Disease (PD).","volume":"9","author":"Bakay","year":"2004","journal-title":"Front. Biosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.stem.2014.09.016","article-title":"Developing stem cell therapies for Parkinson\u2019s disease: waiting until the time is right.","volume":"15","author":"Barker","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson\u2019s disease.","volume":"12","author":"Barker","year":"","journal-title":"Lancet Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jnnp-2012-302441","article-title":"The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington\u2019s disease.","volume":"84","author":"Barker","year":"","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nrneurol.2015.123","article-title":"Cell-based therapies for Parkinson disease-past insights and future potential.","volume":"11","author":"Barker","year":"","journal-title":"Nat. Rev. Neurol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/npjparkd.2015.17","article-title":"G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson\u2019s disease.","volume":"1","author":"Barker","year":"","journal-title":"NPJ Park. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","article-title":"Designing stem-cell-based dopamine cell replacement trials for Parkinson\u2019s disease.","volume":"25","author":"Barker","year":"2019","journal-title":"Nat. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","article-title":"Human trials of stem cell-derived dopamine neurons for Parkinson\u2019s disease: dawn of a new era.","volume":"21","author":"Barker","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1602\/neurorx.1.4.472","article-title":"Immune problems in central nervous system cell therapy.","volume":"1","author":"Barker","year":"2004","journal-title":"NeuroRx"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.5772\/31359","article-title":"BDNF in Huntington\u2019s disease: role in pathogenesis and treatment","author":"Baydyuk","year":"2012","journal-title":"Huntington\u2019s Disease - Core Concepts Currurent Advance"},{"key":"B31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s13311-011-0075-8","article-title":"Cellular therapy and induced neuronal replacement for Huntington\u2019s disease.","volume":"8","author":"Benraiss","year":"2011","journal-title":"Neurotherapeutics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.tins.2007.08.007","article-title":"Neuronal \u201cOn\u201d and \u201cOff\u201d signals control microglia.","volume":"30","author":"Biber","year":"2007","journal-title":"Trends Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0006-8993(79)90472-4","article-title":"Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.","volume":"177","author":"Bj\u00f6rklund","year":"1979","journal-title":"Brain Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease.","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability.","volume":"8","author":"Blesa","year":"2014","journal-title":"Front. Neuroanat."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease.","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v7.i3.179","article-title":"Historical perspective of cell transplantation in Parkinson\u2019s disease.","volume":"7","author":"Boronat-Garc\u00eda","year":"2017","journal-title":"World J. Transplant."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2014.00152","article-title":"Molecular determinants of selective dopaminergic vulnerability in Parkinson\u2019s disease: an update.","volume":"8","author":"Brichta","year":"2014","journal-title":"Front. Neuroanat."},{"key":"B39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0962-8924(00)01906-1","article-title":"Integrin-associated protein (CD47) and its ligands.","volume":"11","author":"Brown","year":"2001","journal-title":"Trends Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/brain\/123.7.1380","article-title":"Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson\u2019s disease.","volume":"123","author":"Brundin","year":"2000","journal-title":"Brain"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2014.00211","article-title":"Astrocytic modulation of blood brain barrier: perspectives on Parkinson\u2019s disease.","volume":"8","author":"Cabezas","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease.","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.neuroscience.2009.02.035","article-title":"Histological findings on fetal striatal grafts in a Huntington\u2019s disease patient early after transplantation.","volume":"160","author":"Capetian","year":"2009","journal-title":"Neuroscience"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the huntington disease gene \/ allele-specific silencing of mutant huntingtin.","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-065X.2006.00441.x","article-title":"CNS immune privilege: hiding in plain sight.","volume":"213","author":"Carson","year":"2006","journal-title":"Immunol. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model.","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02122","article-title":"Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis.","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ana.24174","article-title":"Mutant huntingtin is present in neuronal grafts in Huntington disease patients.","volume":"76","author":"Cicchetti","year":"2014","journal-title":"Ann. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"12483","DOI":"10.1073\/pnas.0904239106","article-title":"Neural transplants in patients with Huntington\u2019s disease undergo disease-like neuronal degeneration.","volume":"106","author":"Cicchetti","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B50","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/brain\/awq328","article-title":"Neuronal degeneration in striatal transplants and Huntington\u2019s disease: potential mechanisms and clinical implications.","volume":"134","author":"Cicchetti","year":"2011","journal-title":"Brain"},{"key":"B51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/brain\/aws359","article-title":"Striatal allografts in patients with Huntington\u2019s disease: impact of diminished astrocytes and vascularization on graft viability.","volume":"136","author":"Cisbani","year":"2013","journal-title":"Am. J. Neurol."},{"key":"B52","year":"2018","journal-title":"Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson\u2019s (PD)."},{"key":"B53","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ni0902-807","article-title":"Natural killer cell activation in mice and men: different triggers for similar weapons?","volume":"3","author":"Colucci","year":"2002","journal-title":"Nat. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1007\/s12035-020-01907-4","article-title":"Human pluripotent stem cell-derived neurons are functionally mature in vitro and integrate into the mouse striatum following transplantation.","volume":"57","author":"Comella-Bolla","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"E762","DOI":"10.1073\/pnas.1715865115","article-title":"Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes.","volume":"115","author":"Conforti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.SA."},{"key":"B56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2016.03.031","article-title":"Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin.","volume":"325","author":"Connolly","year":"2016","journal-title":"Neuroscience"},{"key":"B57","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/stem.2747","article-title":"Concise review: the use of stem cells for understanding and treating Huntington\u2019s disease.","volume":"36","author":"Connor","year":"2018","journal-title":"Stem Cells"},{"key":"B58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2009.11.041","article-title":"Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson\u2019s disease.","volume":"1311","author":"Cova","year":"2010","journal-title":"Brain Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington\u2019s disease.","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21062239","article-title":"Recent overview of the use of iPSCs huntington\u2019s disease modeling and therapy.","volume":"21","author":"Csobonyeiova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/546015a","article-title":"Trials of embryonic stem cells to launch in China.","volume":"546","author":"Cyranoski","year":"2017","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pnpbp.2017.06.036","article-title":"The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression.","volume":"80","author":"Czarny","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates.","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models.","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"B65","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/glia.20663","article-title":"Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS.","volume":"56","author":"de Haas","year":"2008","journal-title":"Glia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5581\/1516-8484.20130017","article-title":"Immunological characteristics of mesenchymal stem cells.","volume":"35","author":"de Vasconcellos Machado","year":"2013","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"B67","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nm0397-350","article-title":"Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson\u2019s disease.","volume":"3","author":"Deacon","year":"1997","journal-title":"Nat. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0006-8993(94)90526-6","article-title":"The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidence.","volume":"668","author":"Deacon","year":"1994","journal-title":"Brain Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12015-013-9441-8","article-title":"Human pluripotent stem cell differentiation into authentic striatal projection neurons.","volume":"9","author":"Delli Carri","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4103\/1673-5374.182682","article-title":"Clinical trial perspective for adult and juvenile Huntington\u2019s disease using genetically-engineered mesenchymal stem cells.","volume":"11","author":"Deng","year":"2016","journal-title":"Neural Regen. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in parkinson\u2019s disease.","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons. Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2144\/fsoa-2019-0035","article-title":"Regenerative medicine: could Parkinson\u2019s be the first neurodegenerative disease to be cured?","volume":"5","author":"D\u00edaz","year":"2019","journal-title":"Futur. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a009258","article-title":"Parkinson\u2019s disease and parkinsonism: neuropathology.","volume":"2","author":"Dickson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0014-4886(03)00028-1","article-title":"Motor training effects on recovery of function after striatal lesions and striatal grafts.","volume":"184","author":"D\u00f6br\u00f6ssy","year":"2003","journal-title":"Exp. Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.biochi.2013.06.020","article-title":"The stem cell secretome and its role in brain repair Europe PMC funders group.","volume":"95","author":"Drago","year":"2013","journal-title":"Biochimie"},{"key":"B77","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0079-6123(08)60332-5","article-title":"Adrenal medullary tissue transplants in the caudate nucleus of Parkinson\u2019s patients.","volume":"78","author":"Drucker-Col\u00edn","year":"1988","journal-title":"Prog. Brain Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0188-0128(98)00007-4","article-title":"Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson\u2019s Disease patient. A preliminary report.","volume":"30","author":"Drucker-Col\u00edn","year":"1999","journal-title":"Arch. Med. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2016.11.002","article-title":"Mechanisms and use of neural transplants for brain repair.","volume":"230","author":"Dunnett","year":"2017","journal-title":"Prog. Brain Res."},{"key":"B80","first-page":"394","article-title":"Cell therapy in Huntington\u2019s disease.","volume":"14","author":"Dunnett","year":"2004","journal-title":"NeuroRx J. Am. Soc. Exp. Neuro Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/mot.0b013e32834c2356","article-title":"Clinical translation of cell transplantation in the brain.","volume":"16","author":"Dunnett","year":"2011","journal-title":"Curr. Opin. Organ Transplant."},{"key":"B82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2013.05.004","article-title":"Challenges for taking primary and stem cells into clinical neurotransplantation trials for neurodegenerative disease.","volume":"61","author":"Dunnett","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"E2243","DOI":"10.1073\/pnas.1614412114","article-title":"Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors.","volume":"114","author":"Ehrlich","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B84","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington\u2019s Disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-020-00187-3","article-title":"In vitro modeling of blood-brain barrier and interface functions in neuroimmune communication.","volume":"17","author":"Erickson","year":"2020","journal-title":"Fluids Barr. CNS"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/106529","article-title":"Molecular regulation of striatal development: a review.","volume":"2012","author":"Evans","year":"2012","journal-title":"Anat. Res. Int."},{"key":"B87","doi-asserted-by":"publisher","first-page":"E1234","DOI":"10.1073\/pnas.1611473114","article-title":"Differentiation of human telencephalic progenitor cells into MSNs by inducible expression of Gsx2 and Ebf1.","volume":"114","author":"Faedo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson\u2019s disease.","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2018.00136","article-title":"Brain region-dependent rejection of neural precursor cell transplants.","volume":"11","author":"Fainstein","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-019-0180-x","article-title":"Replacing what\u2019s lost: a new era of stem cell therapy for Parkinson\u2019s disease.","volume":"9","author":"Fan","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"B91","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2147\/NDT.S113998","article-title":"The role of deep brain stimulation in parkinson\u2019s disease: an overview and update on new developments.","volume":"13","author":"Fang","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1212\/WNL.0b013e3181bbff1c","article-title":"Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease.","volume":"73","author":"Farag","year":"2009","journal-title":"Neurology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00401-011-0833-z","article-title":"Glial dysfunction in the pathogenesis of \u03b1-synucleinopathies: emerging concepts.","volume":"121","author":"Fellner","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2020.108741","article-title":"From cell lines to pluripotent stem cells for modelling Parkinson\u2019s disease.","volume":"340","author":"Ferrari","year":"2020","journal-title":"J. Neurosci. Methods"},{"key":"B95","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/096368970000900212","article-title":"Porcine xenografts in Parkinson\u2019s disease and Huntington\u2019s disease patients: preliminary results.","volume":"9","author":"Fink","year":"2000","journal-title":"Cell Transplant."},{"key":"B96","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2217\/rme.15.25","article-title":"Developing stem cell therapies for juvenile and adult-onset Huntington\u2019s disease.","volume":"10","author":"Fink","year":"2015","journal-title":"Regen. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0165-5728(91)90008-U","article-title":"Leukocyte infiltration and glial reactions in xenografts of mouse brain tissue undergoing rejection in the adult rat brain. A light and electron microscopical immunocytochemical study.","volume":"32","author":"Finsen","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson\u2019s disease.","volume":"327","author":"Freed","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/archneur.1990.00530050021007","article-title":"Transplantation of human fetal dopamine cells for Parkinson\u2019s disease: results at 1 year.","volume":"47","author":"Freed","year":"1990","journal-title":"Arch. Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease.","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s13311-011-0082-9","article-title":"Dopamine cell transplantation for Parkinson\u2019s disease: the importance of controlled clinical trials.","volume":"8","author":"Freed","year":"2011","journal-title":"Neurotherapeutics"},{"key":"B102","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","article-title":"Transplanted fetal striatum in Huntington\u2019s disease: phenotypic development and lack of pathology.","volume":"97","author":"Freeman","year":"2000","journal-title":"PNAS"},{"key":"B103","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ana.410380307","article-title":"Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson\u2019s disease.","volume":"38","author":"Freeman","year":"1995","journal-title":"Ann. Neurol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1634\/stemcells.2005-0053","article-title":"Conversion of human umbilical cord mesenchymal stem cells in wharton\u2019s jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism.","volume":"24","author":"Fu","year":"2006","journal-title":"Stem Cells"},{"key":"B105","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ana.20564","article-title":"Positron emission tomography after fetal transplantation in Huntington\u2019s disease.","volume":"58","author":"Furtado","year":"2005","journal-title":"Ann. Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1523\/jneurosci.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington\u2019s disease.","volume":"19","author":"Fusco","year":"1999","journal-title":"J. Neurosci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nn.4597","article-title":"Transcriptomic analysis of purified human cortical microglia reveals age-associated changes.","volume":"20","author":"Galatro","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000360583","article-title":"Human striatum remodelling after neurotransplantation in Huntington\u2019s disease.","volume":"92","author":"Gallina","year":"2014","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"B109","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000155233","article-title":"Human fetal striatal transplantation in Huntington\u2019s disease: a refinement of the stereotactic procedure.","volume":"86","author":"Gallina","year":"","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"B110","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.expneurol.2008.06.003","article-title":"Development of human striatal anlagen after transplantation in a patient with Huntington\u2019s disease.","volume":"213","author":"Gallina","year":"","journal-title":"Exp. Neurol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.expneurol.2009.12.005","article-title":"Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington\u2019s disease patients after transplantation.","volume":"222","author":"Gallina","year":"2010","journal-title":"Exp. Neurol."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00669","article-title":"Huntington\u2019s disease patient-derived astrocytes display electrophysiological impairments and reduced neuronal support.","volume":"13","author":"Garcia","year":"2019","journal-title":"Front. Neurosci."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/srep34478","article-title":"Neural stem cell tumorigenicity and biodistribution assessment for Phase I clinical trial in Parkinson\u2019s disease.","volume":"6","author":"Garitaonandia","year":"2016","journal-title":"Sci. Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1089\/scd.2018.0001","article-title":"Novel approach to stem cell therapy in Parkinson\u2019s disease.","volume":"27","author":"Garitaonandia","year":"2018","journal-title":"Stem Cells Dev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/brain\/awh003","article-title":"Striatal neural grafting improves cortical metabolism in Huntington\u2019s disease patients.","volume":"127","author":"Gaura","year":"2004","journal-title":"Brain"},{"key":"B116","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/J.CELL.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"B117","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/gtmb.2011.0252","article-title":"DNA repair genes in Parkinson\u2019s disease.","volume":"16","author":"Gencer","year":"2012","journal-title":"Genet. Test. Mol. Biomark."},{"key":"B118","doi-asserted-by":"publisher","first-page":"7553","DOI":"10.1523\/jneurosci.14-12-07553.1994","article-title":"Long-term delayed vascularization of human neural transplants to the rat brain.","volume":"14","author":"Geny","year":"1994","journal-title":"J. Neurosci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease.","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00455","article-title":"On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease.","volume":"9","author":"Gigu\u00e8re","year":"2018","journal-title":"Front. Neurol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000100221","article-title":"Transplantation of adrenal medullary tissue to caudate nucleus using stereotactic techniques.","volume":"54","author":"Gildenberg","year":"1990","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1212\/wnl.41.11.1719","article-title":"United parkinson foundation neurotransplantation registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up.","volume":"41","author":"Goetz","year":"1991","journal-title":"Neurology"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal3222","article-title":"An environment-dependent transcriptional network specifies human microglia identity.","volume":"356","author":"Gosselin","year":"2017","journal-title":"Science"},{"key":"B124","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood \u2013 brain barrier permeability in Parkinson\u2019s disease.","volume":"35","author":"Gray","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1523\/JNEUROSCI.09-09-03250.1989","article-title":"Intrastriatal grafts derived from fetal striatal primordia. I. Phenotypy and modular organization.","volume":"9","author":"Graybiel","year":"1989","journal-title":"J. Neurosci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","article-title":"Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson\u2019s disease.","volume":"15","author":"Grealish","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1474-4422(11)70097-7","article-title":"Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson\u2019s disease: a double-blind, randomised, controlled trial.","volume":"10","author":"Gross","year":"2011","journal-title":"Lancet Neurol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3892\/ijmm.2018.3406","article-title":"Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s Disease.","volume":"41","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"B129","first-page":"36","article-title":"Differentiation of mesenchymal stem cells into dopaminergic neuron-like cells in vitro.","volume":"18","author":"Guo","year":"2005","journal-title":"Biomed. Environ. Sci."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01008","article-title":"Neuroinflammation as a common feature of neurodegenerative disorders.","volume":"10","author":"Guzman-Martinez","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/brain\/122.6.1121","article-title":"Sequential bilateral transplantation in Parkinson\u2019s disease: effects of the second graft.","volume":"122","author":"Hagell","year":"1999","journal-title":"Brain"},{"key":"B132","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1293\/tox.2016-0075","article-title":"The lymphoid system: a review of species differences.","volume":"30","author":"Haley","year":"2017","journal-title":"J. Toxicol. Pathol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson\u2019s disease.","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B134","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2004.6.3\/ahartmann","article-title":"Postmortem studies in Parkinson\u2019s disease.","volume":"6","author":"Hartmann","year":"2004","journal-title":"Dialog. Clin. Neurosci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/archneur.56.2.179","article-title":"Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.","volume":"56","author":"Hauser","year":"1999","journal-title":"Arch. Neurol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1212\/WNL.58.5.687","article-title":"Bilateral human fetal striatal transplantation in Huntington\u2019s disease.","volume":"58","author":"Hauser","year":"","journal-title":"Neurology"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.11.1704","article-title":"Bilateral human fetal striatal transplantation in Huntington\u2019s disease [1] (multiple letters).","volume":"58","author":"Hauser","year":"","journal-title":"Neurology"},{"key":"B138","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.3233\/JPD-181488","article-title":"Repairing the brain: cell replacement using stem cell-based technologies.","volume":"8","author":"Henchcliffe","year":"2018","journal-title":"J. Parkinsons. Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration.","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.410270615","article-title":"Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson\u2019s disease?","volume":"27","author":"Hirsch","year":"1990","journal-title":"Ann. Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuroscience.2015.07.014","article-title":"GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson\u2019s disease.","volume":"303","author":"Hoban","year":"2015","journal-title":"Neuroscience"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/sctm.16-0434","article-title":"Concise review: innate and adaptive immune recognition of allogeneic and xenogeneic cell transplants in the central nervous system.","volume":"6","author":"Hoornaert","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41598-017-09097-1","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study.","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8090177","article-title":"Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches.","volume":"8","author":"Hussain","year":"2018","journal-title":"Brain Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/jnr.21652","article-title":"Immune or inflammatory response by the host brain suppresses neuronal differentiation of transplanted ES cell\u2013derived neural precursor cells.","volume":"86","author":"Ideguchi","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molmed.2017.01.004","article-title":"Immune regulation of antibody access to neuronal tissues.","volume":"23","author":"Iwasaki","year":"2017","journal-title":"Trends Mol. Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201809575","article-title":"Cellular, molecular, and clinical mechanisms of action of deep brain stimulation\u2014a systematic review on established indications and outlook on future developments.","volume":"11","author":"Jakobs","year":"2019","journal-title":"Embo Mol. Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"43","DOI":"10.15283\/ijsc.2014.7.1.43","article-title":"In vivo roles of a patient-derived induced pluripotent stem cell line (HD72-iPSC) in the YAC128 model of huntington\u2019s disease.","volume":"7","author":"Jeon","year":"2014","journal-title":"Int. J. Stem Cells"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/stem.1135","article-title":"Neuronal properties, in vivo effects, and pathology of a Huntington\u2019s disease patient-derived induced pluripotent stem cells.","volume":"30","author":"Jeon","year":"2012","journal-title":"Stem Cells"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3945403","article-title":"Promising therapeutic strategies for mesenchymal stem cell-based cardiovascular regeneration: from cell priming to tissue engineering.","volume":"2017","author":"Ji","year":"2017","journal-title":"Stem Cells Int."},{"key":"B151","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1179\/016164110X12816242542571","article-title":"Bone marrow mesenchymal stem cells can improve the motor function of a Huntington\u2019s disease rat model.","volume":"33","author":"Jiang","year":"2011","journal-title":"Neurol. Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/brain\/awm070","article-title":"Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cells.","volume":"130","author":"Joannides","year":"2007","journal-title":"Brain"},{"key":"B153","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.stem.2012.07.007","article-title":"Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells.","volume":"11","author":"Karow","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B154","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0896-6273(00)00083-0","article-title":"Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.","volume":"28","author":"Kawasaki","year":"2000","journal-title":"Neuron"},{"key":"B155","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-008-0465-0","article-title":"A patient with Huntington\u2019s disease and long-surviving fetal neural transplants that developed mass lesions.","volume":"117","author":"Keene","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1212\/01.wnl.0000264504.14301.f5","article-title":"Neural transplantation in Huntington disease: long-term grafts in two patients.","volume":"68","author":"Keene","year":"2007","journal-title":"Neurology"},{"key":"B157","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","article-title":"Long-term clinical outcome of fetal cell transplantation for parkinson disease: two case reports.","volume":"71","author":"Kefalopoulou","year":"2014","journal-title":"Jama Neurol."},{"key":"B158","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.90.15_supplement.S26.002","article-title":"Interim clinical assessment of a neural stem cell based therapy for Parkinson\u2019s disease.","volume":"90","author":"Kern","year":"2018","journal-title":"Neurology"},{"key":"B159","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4103\/1735-5362.258487","article-title":"Differentiation of adult human mesenchymal stem cells into dopaminergic neurons.","volume":"14","author":"Khademizadeh","year":"2019","journal-title":"Res. Pharm. Sci."},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019025","article-title":"Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in Hemiparkinsonian rodents.","volume":"6","author":"Khoo","year":"2011","journal-title":"PLoS One"},{"key":"B161","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model.","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"B162","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JPD-2011-11070","article-title":"Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson\u2019s disease.","volume":"1","author":"Kikuchi","year":"2011","journal-title":"J. Parkinsons. Dis."},{"key":"B163","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature00900","article-title":"Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson\u2019s disease.","volume":"418","author":"Kim","year":"2002","journal-title":"Nature"},{"key":"B164","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.celrep.2012.04.009","article-title":"Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions.","volume":"1","author":"Kirkeby","year":"2012","journal-title":"Cell Rep."},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/873706","article-title":"Parkinson\u2019s disease and mesenchymal stem cells: potential for cell-based therapy.","volume":"2012","author":"Kitada","year":"2012","journal-title":"Parkinsons. Dis."},{"key":"B166","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/NEN.0b013e3181964113","article-title":"Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.","volume":"68","author":"Koning","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/exnr.1997.6685","article-title":"Safety of intrastriatal neurotransplantation for Huntington\u2019s disease patients.","volume":"149","author":"Kopyov","year":"1998","journal-title":"Exp. Neurol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/mds.870130303","article-title":"Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson\u2019s disease.","volume":"13","author":"Kordower","year":"1998","journal-title":"Mov. Disord."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJM199504273321702","article-title":"Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with parkinson\u2019s disease.","volume":"332","author":"Kordower","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/(sici)1096-9861(19960624)370:2<203::aid-cne6>3.0.co;2-6","article-title":"Functional fetal nigral grafts in a patient with Parkinson\u2019s disease: chemoanatomic, ultrastructural, and metabolic studies.","volume":"370","author":"Kordower","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0963-6897(97)00019-5","article-title":"Fetal grafting for Parkinson\u2019s disease: expression of immune markers in two patients with functional fetal nigral implants.","volume":"6","author":"Kordower","year":"1997","journal-title":"Cell Transplant."},{"key":"B172","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781107588660","author":"Kovacs","year":"2014","journal-title":"Neuropathology of Neurodegenerative Diseases: A Practical Guide."},{"key":"B173","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/pl00022913","article-title":"Thalamic, pallidal, or subthalamic surgery for Parkinson\u2019s disease?","volume":"247","author":"Krack","year":"2000","journal-title":"J. Neurol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1759-1961.2011.00018.x","article-title":"Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington\u2019s disease: consequences for cerebral transplantation programs.","volume":"2","author":"Krebs","year":"2011","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00005072-199007000-00002","article-title":"Atrophy of the hypothalamic lateral tuberal nucleus in Huntington\u2019s disease.","volume":"49","author":"Kremer","year":"1990","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease.","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000166","article-title":"Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington\u2019s disease.","volume":"2","author":"Krystkowiak","year":"2007","journal-title":"PLoS One"},{"key":"B178","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1523\/JNEUROSCI.4846-11.2012","article-title":"Bone marrow transplantation confers modest benefits in mouse models of Huntington\u2019s disease.","volume":"32","author":"Kwan","year":"2012","journal-title":"J. Neurosci."},{"key":"B179","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly.","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"B180","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/978-1-4939-7825-0_23","article-title":"Translating antisense technology into a treatment for Huntington\u2019s disease.","volume":"1780","author":"Lane","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1365-3083.2000.00796.x","article-title":"Neural tissue xenografting.","volume":"52","author":"Larsson","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain.","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.0299","article-title":"Huntingtin-lowering therapies for hu wntington disease: a review of the evidence of potential benefits and risks.","author":"Leavitt","year":"2020","journal-title":"JAMA Neurol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aba4624","article-title":"Antisense oligonucleotides for neurodegeneration.","volume":"367","author":"Leavitt","year":"2020","journal-title":"Science"},{"key":"B185","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3171\/jns.1994.81.2.0272","article-title":"Vascularization and microvascular permeability in solid versus cell- suspension embryonic neural grafts.","volume":"81","author":"Leigh","year":"1994","journal-title":"J. Neurosurg."},{"key":"B186","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.2174\/0929867311209066018","article-title":"The use of stem cells in regenerative medicine for Parkinson\u2019s and Huntington\u2019s diseases.","volume":"19","author":"Lescaudron","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s11427-016-0165-3","article-title":"Accelerated generation of oligodendrocyte progenitor cells from human induced pluripotent stem cells by forced expression of Sox10 and Olig2.","volume":"59","author":"Li","year":"","journal-title":"Sci. China Life Sci."},{"key":"B188","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.","volume":"113","author":"Li","year":"","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022924","article-title":"Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington\u2019s disease mouse models.","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"B190","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410220403","article-title":"Transplantation in Parkinson\u2019s disease: two cases of adrenal medullary grafts to the putamen.","volume":"22","author":"Lindvall","year":"1987","journal-title":"Ann. Neurol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of fetal dopamine neurons survive and improve motor function in Parkinson\u2019s disease.","volume":"247","author":"Lindvall","year":"1990","journal-title":"Science"},{"key":"B192","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","article-title":"Human fetal dopamine neurons grafted into the striatum in two patients with severe parkinson\u2019s disease: a detailed account of methodology and a 6-month follow-up.","volume":"46","author":"Lindvall","year":"1989","journal-title":"Arch. Neurol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ana.410350208","article-title":"Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson\u2019s disease.","volume":"35","author":"Lindvall","year":"1994","journal-title":"Ann. Neurol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.expneurol.2007.08.019","article-title":"Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson\u2019s disease?","volume":"209","author":"Lindvall","year":"2008","journal-title":"Exp. Neurol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ana.410310206","article-title":"Transplantation of fetal dopamine neurons in Parkinson\u2019s disease: one-year clinical and neurophysiological observations in two patients with putaminal implants.","volume":"31","author":"Lindvall","year":"1992","journal-title":"Ann. Neurol."},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00645","article-title":"The immunogenicity and immune tolerance of pluripotent stem cell derivatives.","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuron.2016.08.027","article-title":"Lymphatics in neurological disorders: a neuro-lympho-vascular component of multiple sclerosis and Alzheimer\u2019s disease.","volume":"91","author":"Louveau","year":"","journal-title":"Neuron"},{"key":"B198","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.it.2015.08.006.Revisiting","article-title":"Revisiting the concept of CNS immune privilege.","volume":"36","author":"Louveau","year":"","journal-title":"Trends Immunol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels.","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"B200","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.neuron.2012.06.001","article-title":"\u201cHuntingtin holiday\u201d: progress toward an antisense therapy for Huntington\u2019s disease.","volume":"74","author":"Lu","year":"2012","journal-title":"Neuron"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2019.00355","article-title":"Intravenously injected mesenchymal stem cells penetrate the brain and treat inflammation-induced brain damage and memory impairment in mice.","volume":"10","author":"Lykhmus","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2967\/jnumed.109.066811","article-title":"Dopamine cell implantation in Parkinson\u2019s disease: long-term clinical and18F-FDOPA PET outcomes.","volume":"51","author":"Ma","year":"2010","journal-title":"J. Nucl. Med."},{"key":"B203","first-page":"109","article-title":"The first homotopic fetal homograft of the striatum in the treatment of Huntington\u2019s disease.","volume":"129","author":"Madrazo","year":"1993","journal-title":"Gac. Med. Mex."},{"key":"B204","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1056\/NEJM198704023161402","article-title":"Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson\u2019s disease.","volume":"316","author":"Madrazo","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"B205","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/01616412.1995.11740334","article-title":"Fetal striatal homotransplantation for Huntington\u2019s disease: first two case reports.","volume":"17","author":"Madrazo","year":"1995","journal-title":"Neurol. Res."},{"key":"B206","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/0963689718820271","article-title":"Transplantation of human neural progenitor cells (NPC) into putamina of parkinsonian patients: a case series study, safety and efficacy four years after surgery.","volume":"28","author":"Madrazo","year":"2019","journal-title":"Cell Transplant."},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801073180115","article-title":"Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson\u2019s disease.","volume":"318","author":"Madrazo","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"B208","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1523\/jneurosci.20-16-06063.2000","article-title":"Origin and molecular specification of striatal interneurons.","volume":"20","author":"Mar\u00edn","year":"2000","journal-title":"J. Neurosci."},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.c0ad575f12106c38f9f5717a8a7d05ae","article-title":"Large-sized fetal striatal grafts in Huntington\u2019s disease do stop growing. long-term monitoring in the florence experience.","volume":"6","author":"Mascalchi","year":"2014","journal-title":"PLoS Curr."},{"key":"B210","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"B211","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ana.25354","article-title":"Outcome of cell suspension allografts in a patient with Huntington\u2019s disease.","volume":"84","author":"Maxan","year":"2018","journal-title":"Ann. Neurol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/j.1460-9568.2009.07006.x","article-title":"Embryonic striatal grafts restore bi-directional synaptic plasticity in a rodent model of Huntington\u2019s disease.","volume":"30","author":"Mazzocchi-Jones","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"B213","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.3727\/096368912X658809","article-title":"Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington\u2019s disease.","volume":"22","author":"McLeod","year":"2013","journal-title":"Cell Transplant."},{"key":"B214","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/NRL.0000000000000188","article-title":"Therapy with mesenchymal stem cells in parkinson disease.","volume":"23","author":"Mendes Filho","year":"2018","journal-title":"Neurologist"},{"key":"B215","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3171\/jns.2002.96.3.0589","article-title":"Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study.","volume":"96","author":"Mendez","year":"2002","journal-title":"J. Neurosurg."},{"key":"B216","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3171\/jns.2000.92.5.0863","article-title":"Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line- derived neurotrophic factor in patients with Parkinson\u2019s disease.","volume":"92","author":"Mendez","year":"2000","journal-title":"J. Neurosurg."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/brain\/awh510","article-title":"Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson\u2019s disease.","volume":"128","author":"Mendez","year":"2005","journal-title":"Brain"},{"key":"B218","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology.","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.parkreldis.2011.10.021","article-title":"An evidence-based approach in the treatment of Huntington\u2019s disease.","volume":"18","author":"Mestre","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"B220","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jnnp.2006.106021","article-title":"Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study.","volume":"78","author":"M\u00ednguez-Castellanos","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B221","doi-asserted-by":"publisher","first-page":"02","DOI":"10.3390\/brainsci7060063","article-title":"Striatal vulnerability in huntington\u2019s disease: neuroprotection versus neurotoxicity.","volume":"7","author":"Morigaki","year":"2017","journal-title":"Brain Sci."},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates.","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat. Commun."},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00127","article-title":"Multiple aspects of gene dysregulation in Huntington\u2019s disease.","volume":"4","author":"Moumn\u00e9","year":"2013","journal-title":"Front. Neurol."},{"key":"B224","year":"2005","journal-title":"MIG-HD: Multicentric Intracerebral Grafting in Huntington\u2019s Disease."},{"key":"B225","year":"2005","journal-title":"STEPS Trial - Spheramine Safety and Efficacy Study."},{"key":"B226","year":"2013","journal-title":"TRANSEURO Open Label Transplant Study in Parkinson\u2019s Disease."},{"key":"B227","article-title":"A study to evaluate the safety of neural stem cells in patients with Parkinson\u2019s disease.","year":"2015"},{"key":"B228","year":"2016","journal-title":"Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington\u2019s Disease."},{"key":"B229","year":"2016","journal-title":"Parkinsonian Brain Repair Using Human Stem Cells (HSCfPD)."},{"key":"B230","year":"2017","journal-title":"Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson\u2019s Disease."},{"key":"B231","year":"2017","journal-title":"Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington\u2019s Disease."},{"key":"B232","year":"2018","journal-title":"A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients With Manifest Huntington\u2019s Disease."},{"key":"B233","year":"2020","journal-title":"Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington\u2019s Patients."},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2232","article-title":"Subthalamic and pallidal deep brain stimulation for Parkinson\u2019s disease.","volume":"10","author":"Negida","year":"2018","journal-title":"Cureus"},{"key":"B235","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/1876893800901010020","article-title":"Therapeutic microinjection of autologous adult human neural stem cells and differentiated neurons for Parkinson\u2019s disease: five-year post-operative outcome.","volume":"1","author":"Neuman","year":"2009","journal-title":"Open Stem Cell J."},{"key":"B236","doi-asserted-by":"publisher","first-page":"937","DOI":"10.5966\/sctm.2016-0073","article-title":"Efficiently specified ventral midbrain dopamine neurons from human pluripotent stem cells under xeno-free conditions restore motor deficits in parkinsonian rodents.","volume":"6","author":"Niclis","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"B237","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/stem.1462","article-title":"Embryonic stem cells neural differentiation qualifies the role of Wnt\/\u03b2-Catenin signals in human telencephalic specification and regionalization.","volume":"31","author":"Nicoleau","year":"2013","journal-title":"Stem Cells"},{"key":"B238","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1224-y","article-title":"Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.","volume":"10","author":"Noronha, Nc","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"B239","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease.","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0306-4522(97)00532-0","article-title":"Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence.","volume":"84","author":"Olsson","year":"1998","journal-title":"Neuroscience"},{"key":"B241","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/0306-4522(95)00325-D","article-title":"Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence.","volume":"69","author":"Olsson","year":"1995","journal-title":"Neuroscience"},{"key":"B242","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jnnp-2013-306533","article-title":"Fetal striatal grafting slows motor and cognitive decline of Huntington\u2019s disease.","volume":"85","author":"Paganini","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00258","article-title":"The role of microglia and astrocytes in Huntington\u2019s disease.","volume":"12","author":"Palpagama","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1471-4159.2004.03006.x","article-title":"In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons.","volume":"92","author":"Park","year":"2005","journal-title":"J. Neurochem."},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2012.00016","article-title":"Restoration of the striatal circuitry: from developmental aspects towards clinical applications.","volume":"6","author":"Pauly","year":"2012","journal-title":"Front. Cell. Neurosci."},{"key":"B246","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s0963-6897(97)00030-4","article-title":"Colonization of neural allografts by host microglial cells: relationship to graft neovascularization.","volume":"6","author":"Pennell","year":"1997","journal-title":"Cell Transplant."},{"key":"B247","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2307\/1748187","article-title":"Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system.","volume":"204","author":"Perlow","year":"1979","journal-title":"Science"},{"key":"B248","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/cne.902740311","article-title":"Fetal homotypic transplant in the excitotoxically neuron-depleted thalamus: light microscopy.","volume":"274","author":"Peschanski","year":"1988","journal-title":"J. Comp. Neurol."},{"key":"B249","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1212\/wnl.39.2.235","article-title":"Autopsy findings in a patient who had an adrenal-to-brain transplant for parkinson\u2019s disease.","volume":"39","author":"Peterson","year":"1989","journal-title":"Neurology"},{"key":"B250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a020628","article-title":"Astrocytes in neurodegenerative disease.","volume":"7","author":"Phatnani","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0963-6897(97)00028-6","article-title":"Neuropsychological functioning following fetal striatal transplantation in Huntington\u2019s chorea: three case presentations.","volume":"6","author":"Philpott","year":"1997","journal-title":"Cell Transplant."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/16060","article-title":"Dopamine release from nigral transplants visualized in vivo in a Parkinson\u2019s patient.","volume":"2","author":"Piccini","year":"1999","journal-title":"Nat. Neurosci."},{"key":"B253","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/1531-8249(200011)48:5<689::AID-ANA1<3.0.CO;2-N","article-title":"Delayed recovery of movement-related cortical function in Parkinson\u2019s disease after striatal dopaminergic grafts.","volume":"48","author":"Piccini","year":"2000","journal-title":"Ann. Neurol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/BEN-2012-120267","article-title":"The pathophysiology and pharmacological treatment of Huntington disease.","volume":"26","author":"Pidgeon","year":"2013","journal-title":"Behav. Neurol."},{"key":"B255","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.brainresbull.2012.03.001","article-title":"The immunological challenges of cell transplantation for the treatment of Parkinson\u2019s disease.","volume":"88","author":"Piquet","year":"2012","journal-title":"Brain Res. Bull."},{"key":"B256","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington\u2019s disease gene carriers.","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B257","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/mt.2016.12","article-title":"Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in huntington\u2019s disease mouse models.","volume":"24","author":"Pollock","year":"2016","journal-title":"Mol. Ther."},{"key":"B258","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3727\/096368913X676222","article-title":"Donor-specific Anti-HLA antibodies in Huntington\u2019s disease recipients of human fetal striatal grafts.","volume":"24","author":"Porfirio","year":"2015","journal-title":"Cell Transplant."},{"key":"B259","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuint.2017.01.016","article-title":"Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington\u2019s disease?","volume":"106","author":"Precious","year":"2017","journal-title":"Neurochem. Int."},{"key":"B260","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nprot.2017.152","article-title":"Generation of human brain region\u2013specific organoids using a miniaturized spinning bioreactor.","volume":"13","author":"Qian","year":"2018","journal-title":"Nat. Protoc."},{"key":"B261","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/SCD.2010.0466","article-title":"Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans.","volume":"20","author":"Ra","year":"2011","journal-title":"Stem Cells Dev."},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2019.00435","article-title":"Organ-On-A-Chip in vitro models of the brain and the blood-brain barrier and their value to study the microbiota-gut-brain axis in neurodegeneration.","volume":"7","author":"Raimondi","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/JCI58644.The","article-title":"Innate immunity in the central nervous system.","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B264","doi-asserted-by":"publisher","first-page":"46","DOI":"10.22074\/cellj.2018.4777","article-title":"Co-transplantation of human neurotrophic factor secreting cells and adipose-derived stem cells in rat model of multiple sclerosis.","volume":"20","author":"Razavi","year":"2018","journal-title":"Cell J."},{"key":"B265","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease.","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B266","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/jnnp.2007.142380","article-title":"Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington\u2019s disease.","volume":"79","author":"Reuter","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B267","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4103\/1673-5374.255978","article-title":"Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer\u2019s disease.","volume":"14","author":"Reza-Zaldivar","year":"2019","journal-title":"Neural Regen. Res."},{"key":"B268","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1089\/scd.2015.0127","article-title":"A meta-analysis of mesenchymal stem cells in animal models of Parkinson\u2019s disease.","volume":"24","author":"Riecke","year":"2015","journal-title":"Stem Cells Dev."},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8653132","article-title":"Neuroimmunology of Huntington\u2019s Disease: revisiting evidence from human studies.","volume":"2016","author":"Rocha","year":"2016","journal-title":"Media. Inflamm."},{"key":"B270","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(SICI)1099-1492(199906)12:4<221::AID-NBM582<3.0.CO;2-Q","article-title":"In vivo magnetic resonance spectroscopy of human fetal neural transplants.","volume":"12","author":"Ross","year":"1999","journal-title":"NMR Biomed."},{"key":"B271","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease.","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"B272","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","article-title":"Unilateral transplantation of human primary fetal tissue in four patients with Huntington\u2019s disease: NEST-UK safety report ISRCTN no 36485475.","volume":"73","author":"Rosser","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B273","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/nm1495","article-title":"Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.","volume":"12","author":"Roy","year":"2006","journal-title":"Nat. Med."},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection.","volume":"2","author":"Ryan","year":"2005","journal-title":"J. Inflamm."},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101805","article-title":"Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms.","volume":"190","author":"Sabogal-Gu\u00e1queta","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01935","article-title":"Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset.","volume":"8","author":"Sachamitr","year":"2018","journal-title":"Front. Immunol."},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00249","article-title":"Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities.","volume":"9","author":"Salgado","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00093","article-title":"Lack of helios during neural development induces adult schizophrenia-like behaviors associated with aberrant levels of the TRIF-recruiter protein WDFY1.","volume":"14","author":"Sancho-Balsells","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"B279","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin.","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"B280","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-3-211-45295-0_57","article-title":"Role of cytokines in inflammatory process in Parkinson\u2019s disease.","volume":"70","author":"Sawada","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"B281","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.410310207","article-title":"Transplantation of fetal dopamine neurons in Parkinson\u2019s disease: PET {18F}6-L-fluorodopa studies in two patients with putaminal implants.","volume":"31","author":"Sawle","year":"1992","journal-title":"Ann. Neurol."},{"key":"B282","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbr.2013.07.053","article-title":"Donor age dependent graft development and recovery in a rat model of Huntington\u2019s disease: histological and behavioral analysis.","volume":"256","author":"Schackel","year":"2013","journal-title":"Behav. Brain Res."},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01905","article-title":"Neuroinflammation: microglia and T cells get ready to tango.","volume":"8","author":"Schetters","year":"2018","journal-title":"Front. Immunol."},{"key":"B284","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.94.15_supplement.1877","article-title":"Safety and tolerability of bone marrow-derived allogeneic mesenchymal stem cells in Parkinson\u2019s disease patients (1877).","volume":"94","author":"Schiess","year":"2020","journal-title":"Neurology"},{"key":"B285","article-title":"Safety of bone marrow-derived allogeneic mesenchymal stem cells in Parkinson\u2019s disease patients [abstract].","volume":"34","author":"Schiess","year":"2019","journal-title":"Mov. Disord."},{"key":"B286","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/WNL.54.5.1042","article-title":"Transplantation of embryonic porcine mesencephalic tissue in patients with PD.","volume":"54","author":"Schumacher","year":"2000","journal-title":"Neurology"},{"key":"B287","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMOA1915872","article-title":"Personalized iPSC-Derived dopamine progenitor cells for Parkinson\u2019s disease.","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B288","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41551-019-0401-8","article-title":"Universally non-immunogenic iPSCs.","volume":"3","author":"Shani","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"B289","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-11028-z","article-title":"Synergistic effect of BDNF and FGF2 in efficient generation of functional dopaminergic neurons from human mesenchymal stem cells.","volume":"7","author":"Singh","year":"2017","journal-title":"Sci. Rep."},{"key":"B290","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.parkreldis.2018.11.015","article-title":"A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL\u00ae [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson\u2019s disease.","volume":"61","author":"Snow","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009347","article-title":"Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington\u2019s disease.","volume":"5","author":"Snyder","year":"2010","journal-title":"PLoS One"},{"key":"B292","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12015-014-9574-4","article-title":"Banking on iPSC- is it doable and is it worthwhile.","volume":"11","author":"Solomon","year":"2015","journal-title":"Stem Cell Rev. Rep."},{"key":"B293","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2007.05.066","article-title":"Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions.","volume":"423","author":"Song","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B294","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1634\/stemcells.2006-0380","article-title":"Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.","volume":"25","author":"Sonntag","year":"2007","journal-title":"Stem Cells"},{"key":"B295","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B296","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies.","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B297","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000098976","article-title":"Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington\u2019s chorea.","volume":"58","author":"\u0160ramka","year":"1992","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"B298","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.mayocp.2019.01.001","article-title":"Mesenchymal stromal cell therapies for neurodegenerative diseases.","volume":"94","author":"Staff","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"B299","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3124","article-title":"Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson\u2019s disease model.","volume":"33","author":"Steinbeck","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"B300","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases.","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"key":"B301","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.brainres.2017.07.005","article-title":"Co-transplantation of mesenchymal and neural stem cells and overexpressing stromal-derived factor-1 for treating spinal cord injury.","volume":"1672","author":"Stewart","year":"2017","journal-title":"Brain Res."},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010026","article-title":"Treatment of Parkinson\u2019s disease through personalized medicine and induced pluripotent stem cells.","volume":"8","author":"Stoddard-Bennett","year":"2019","journal-title":"Cells"},{"key":"B303","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1001\/archneur.62.12.1833","article-title":"Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.","volume":"62","author":"Stover","year":"2005","journal-title":"Arch. Neurol."},{"key":"B304","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neuroscience.2016.07.022","article-title":"Human t-DARPP is induced during striatal development.","volume":"333","author":"Straccia","year":"2016","journal-title":"Neuroscience"},{"key":"B305","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.25095","article-title":"Neuronal vulnerability, pathogenesis, and Parkinson\u2019s disease.","volume":"28","author":"Sulzer","year":"2013","journal-title":"Mov. Disord."},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1177\/0963689720908512","article-title":"GDNF promotes survival and therapeutic efficacy of human adipose-derived mesenchymal stem cells in a mouse model of Parkinson\u2019s disease.","volume":"29","author":"Sun","year":"2020","journal-title":"Cell Transplant."},{"key":"B307","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington\u2019s disease.","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"key":"B308","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1098\/rstb.2011.0030","article-title":"Immunological considerations for embryonic and induced pluripotent stem cell banking.","volume":"366","author":"Taylor","year":"2011","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"B309","doi-asserted-by":"publisher","first-page":"634","DOI":"10.5966\/sctm.2016-0071","article-title":"Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson\u2019s disease.","volume":"6","author":"Teixeira","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"B310","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-4939-9007-8_8","article-title":"Midbrain dopaminergic neurons differentiated from human-induced pluripotent stem cells","author":"Tofoli","year":"2019","journal-title":"Neural Stem Cells: Methods and Protocols"},{"key":"B311","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1523\/jneurosci.23-01-00141.2003","article-title":"Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats.","volume":"23","author":"Toledo-Aral","year":"2003","journal-title":"J. Neurosci."},{"key":"B312","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-2-24","article-title":"The microglial \u201cactivation\u201d continuum: from innate to adaptive responses.","volume":"2","author":"Town","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"B313","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1471-4159.2009.06201.x","article-title":"Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons.","volume":"110","author":"Trzaska","year":"2009","journal-title":"J. Neurochem."},{"key":"B314","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1634\/stemcells.2007-0212","article-title":"Specification of a dopaminergic phenotype from adult human mesenchymal stem cells.","volume":"25","author":"Trzaska","year":"2007","journal-title":"Stem Cells"},{"key":"B315","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-1-60761-999-4_22","article-title":"Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells.","volume":"698","author":"Trzaska","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"B316","article-title":"Kyoto trial to evaluate the safety and efficacy of iPSC-derived dopaminergic progenitors in the treatment of Parkinson\u2019s Disease.","year":"2018"},{"key":"B317","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-10359-1","article-title":"Co-encapsulation and co-transplantation of mesenchymal stem cells reduces pericapsular fibrosis and improves encapsulated islet survival and function when allografted.","volume":"7","author":"Vaithilingam","year":"2017","journal-title":"Sci. Rep."},{"key":"B318","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3171\/2016.2.JNS151988","article-title":"Implantation of autologous peripheral nerve grafts into the substantia nigra of subjects with idiopathic Parkinson\u2019s disease treated with bilateral STN DBS: a report of safety and feasibility.","volume":"126","author":"Van Horne","year":"2017","journal-title":"J. Neurosurg."},{"key":"B319","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3171\/2017.8.JNS163222","article-title":"Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson\u2019s disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome.","volume":"129","author":"Van Horne","year":"2018","journal-title":"J. Neurosurg."},{"key":"B320","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00023210-199911020-00003","article-title":"Huntington\u2019s disease: options for controlling symptoms.","volume":"11","author":"Van Vugt","year":"1999","journal-title":"CNS Drugs"},{"key":"B321","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3727\/096368910X494632","article-title":"Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington\u2019s disease.","volume":"19","author":"Vazey","year":"2010","journal-title":"Cell Transplant."},{"key":"B322","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","article-title":"Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson\u2019s disease.","volume":"155","author":"Venkataramana","year":"2010","journal-title":"Transl. Res."},{"key":"B323","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/931902","article-title":"Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson\u2019s disease: a pilot clinical study.","volume":"2012","author":"Venkataramana","year":"2012","journal-title":"Stem Cells Int."},{"key":"B324","doi-asserted-by":"publisher","first-page":"239","DOI":"10.15252\/embj.201592705","article-title":"Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion.","volume":"35","author":"Verkhratsky","year":"2016","journal-title":"Embo J."},{"key":"B325","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ebiom.2018.11.026","article-title":"Neural stem cell derived extracellular vesicles: attributes and prospects for treating neurodegenerative disorders.","volume":"38","author":"Vogel","year":"2018","journal-title":"EBioMedicine"},{"key":"B326","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of huntington\u2019s disease.","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B327","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13311-013-0235-0","article-title":"Surgical treatment of Parkinson\u2019s disease: patients, targets, devices, and approaches.","volume":"11","author":"Wagle Shukla","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054296","article-title":"Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson\u2019s disease.","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"B329","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-3-7091-0643-3_14","article-title":"Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson\u2019s disease.","volume":"65","author":"Watts","year":"2003","journal-title":"J. Neural Transm."},{"key":"B330","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7633.1000421","article-title":"Trans-differentiation of rat mesenchymal stem cells into dopaminergic neurons for cell transplantation.","volume":"8","author":"Welchko","year":"2018","journal-title":"J. Stem Cell Res. Ther."},{"key":"B331","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pathophys.2009.10.007","article-title":"Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis.","volume":"17","author":"Weller","year":"2010","journal-title":"Pathophysiology"},{"key":"B332","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ana.410420115","article-title":"Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson\u2019s disease.","volume":"42","author":"Wenning","year":"1997","journal-title":"Ann. Neurol."},{"key":"B333","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1056\/NEJM199211263272203","article-title":"Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-Methyl-4-Phenyl-L,2,3,6-Tetrahydropyridine (MPTP).","volume":"327","author":"Widner","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B334","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnint.2011.00078","article-title":"The current status of neural grafting in the treatment of Huntington\u2019s disease. A review.","volume":"5","author":"Wijeyekoon","year":"2011","journal-title":"Front. Integr. Neurosci."},{"key":"B335","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1231","article-title":"Abnormal peripheral chemokine profile in Huntington\u2019s disease.","volume":"3","author":"Wild","year":"2011","journal-title":"PLoS Curr."},{"key":"B336","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington\u2019s disease.","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"key":"B337","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1136\/bmj.324.7352.1465","article-title":"Defining neurodegenerative diseases.","volume":"324","author":"Williams","year":"2002","journal-title":"Br. Med. J."},{"key":"B338","doi-asserted-by":"publisher","first-page":"10669","DOI":"10.3390\/ijms150610669","article-title":"Carriers in cell-based therapies for neurological disorders.","volume":"15","author":"Wong","year":"2014","journal-title":"Int J Mol Sci."},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164072","article-title":"A longitudinal operant assessment of cognitive and behavioural changes in the HdhQ111 mouse model of Huntington\u2019s disease.","volume":"11","author":"Yhnell","year":"2016","journal-title":"PLoS One"},{"key":"B340","first-page":"129","article-title":"Pharmacological treatment of Parkinson\u2019s disease","author":"Zahoor","year":"2018","journal-title":"Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects"},{"key":"B341","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","article-title":"Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse neuroresource purification and characterization of progenitor and mature human astrocytes reveals transcriptional.","volume":"89","author":"Zhang","year":"2016","journal-title":"Neuron"},{"key":"B342","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1615\/CritRevImmunol.2014011600","article-title":"Differences in innate immune response between man and mouse.","volume":"34","author":"Zschaler","year":"2014","journal-title":"Crit. Rev. Immunol."},{"key":"B343","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington\u2019s disease.","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fncel.2020.00250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T16:57:34Z","timestamp":1723395454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fncel.2020.00250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":343,"alternative-id":["10.3389\/fncel.2020.00250"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2020.00250","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"article-number":"250"}}